Safety assessment of raloxifene over eight years in a clinical trial setting.

@article{Martino2005SafetyAO,
  title={Safety assessment of raloxifene over eight years in a clinical trial setting.},
  author={Silvana Martino and Damon P. Disch and Sherie A. Dowsett and Cheryl A Keech and John L. Mershon},
  journal={Current medical research and opinion},
  year={2005},
  volume={21 9},
  pages={1441-52}
}
OBJECTIVE Osteoporosis is a chronic disorder that warrants long-term therapy. If benefits are to outweigh risks, the long-term safety profiles of these therapies must be favorable. The aim of this study was to assess the safety of raloxifene over 8 years in 4011 postmenopausal women with osteoporosis in a clinical trial setting through adverse event reporting. METHODS Data analyzed comprised all reported adverse events collected at each visit of both the Multiple Outcomes of Raloxifene… CONTINUE READING